© 1996 by Oxford University Press
Journal of the National Cancer Institute, Vol. 88, No. 8, 530-535,
April 17, 1996
© 1996 Oxford University Press
Genetic Susceptibility to Head and Neck Squamous Cell Carcinoma
Department of Otolaryngology/Head and Neck Surgery, Free University Hospital Amsterdam, The Netherlands
Department of Epidemiology and Biostatistics, Free University Amsterdam, The Netherlands
Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center Houston
Department of Cell Biology, The University of Texas M. D. Anderson Cancer Center Houston
Department of Head and Neck Surgery. Memorial Sloan-Kettering Cancer Center New York, NY
Department of Epidemiology, Memorial Sloan-Kettering Cancer Center New York, NY
Correspondence to: Boudewijn J. M. Braakhuis, Ph.D., Department of Otolaryngology/Head and Neck Surgery. Free University Hospital, P. O. Box 7057. 1007 MB Amsterdam. The Netherlands.
BACKGROUND:: In addition to influences of exposure to carcinogenic compounds, the development of cancer may depend on an individual intrinsic cancer susceptibility. Biomarkers for cancer susceptibility can be powerful additions to epidemiologic analyses.
PURPOSE:: This multicenter, case—control analysis combines previously published data and new data to substantiate the value of mutagen sensitivity as a biomarker of susceptibility to head and neck squamous cell carcinoma and, more importantly, to gain insight into the interaction between susceptibility and exposure to carcinogens.
METHODS:: Mutagen sensitivity (mean number of chromatid breaks per cell of cultured lymphocytes treated with bleomycin in the late S-G2 phase of the cell cycle) was determined in 313 patients with head and neck cancer and in 334 control subjects at two major U.S. medical institutions and one European institution, yielding a unique study population. The ages of the case and control subjects, as well as their history of use of tobacco and alcohol, were also recorded. The relationships between variables were analyzed by use of Student's t tests, Spearman's rank correlations, and multiple linear regression. For estimation of cancer risk, crude odds ratios (ORs) were measured and multiple logistic regression was performed. All P values were based on two-sided tests.
RESULTS:: There were no differences across institutions in the distribution of mutagen sensitivity (Kruskal-Wallis test) for both case subjects and control subjects. Values for case subjects were consistently and significantly (P<.0001) higher than values for control subjects in the overall analyses. Age and tobacco or alcohol use did not influence the outcome in terms of mutagen-sensitivity values for either the case or the control subjects. A mean number of breaks per cell dichotomized at 1.0 was found to be the best predictor of a hypersensitive phenotype. For nonsensitive, heavy smokers, the OR was 11.5 (95% confidence interval [CI] = 5.0–26.6). This risk increased dramatically in mutagen-hypersensitive, heavy smokers to 44.6 (95% CI = 17.4–114.0). Multiple logistic regression analysis confirmed these results, and a significant trend was found (P<.01) for the dose-dependent increase in cancer risk by smoking. The consumption of alcohol potentiated the effects of smoking, resulting in an OR of 57.5 (95% CI = 17.5-188.0) in hypersensitive persons.
CONCLUSIONS:: Mutagen sensitivity was found to be a biomarker of cancer susceptibility. This study underscores the importance of utilizing both susceptibility markers and exposure data for the identification of persons at high risk of developing cancer.
IMPLICATIONS:: More accurate risk estimation can define susceptible subgroups who might be targeted for intensive behavioral interventions, surveillance through screening, and enrollment in chemoprevention programs. [J Natl Cancer Inst 1996;88:530–5]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L.-E Wang, P. Xiong, H. Zhao, M. R. Spitz, E. M. Sturgis, and Q. Wei Chromosome Instability and Risk of Squamous Cell Carcinomas of Head and Neck Cancer Res., June 1, 2008; 68(11): 4479 - 4485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wu, J. Lin, H. B. Grossman, M. Huang, J. Gu, C. J. Etzel, C. I. Amos, C. P. Dinney, and M. R. Spitz Projecting Individualized Probabilities of Developing Bladder Cancer in White Individuals J. Clin. Oncol., November 1, 2007; 25(31): 4974 - 4981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lin, G. E. Swan, P. G. Shields, N. L. Benowitz, J. Gu, C. I. Amos, M. de Andrade, M. R. Spitz, and X. Wu Mutagen Sensitivity and Genetic Variants in Nucleotide Excision Repair Pathway: Genotype-Phenotype Correlation Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2065 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, J. Gu, and M. R. Spitz Mutagen Sensitivity: A Genetic Predisposition Factor for Cancer Cancer Res., April 15, 2007; 67(8): 3493 - 3495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Erdei, S.-J. Lee, Q. Wei, L.-E. Wang, Y.-S. Song, D. Bovbjerg, and M. Berwick Reliability of mutagen sensitivity assay: an inter-laboratory comparison Mutagenesis, July 1, 2006; 21(4): 261 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, M. R. Spitz, C. I. Amos, J. Lin, L. Shao, J. Gu, M. de Andrade, N. L. Benowitz, P. G. Shields, and G. E. Swan Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res., June 15, 2006; 66(12): 5993 - 5996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Natarajan, N. Ganesan, P. Carter-Nolan, C. A. Tucker, P. G. Shields, and L. L. Adams-Campbell {gamma}-Radiation-Induced Chromosomal Mutagen Sensitivity Is Associated with Breast Cancer Risk in African-American Women: Caffeine Modulates the Outcome of Mutagen Sensitivity Assay. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 437 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cloos, W. P.H. de Boer, M. H.J. Snel, P. van den IJssel, B. Ylstra, C. R. Leemans, R. H. Brakenhoff, and B. J.M. Braakhuis Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes Mol. Cancer Res., February 1, 2006; 4(2): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-E Wang, P. Xiong, S. S. Strom, L. H. Goldberg, J. E. Lee, M. I. Ross, P. F. Mansfield, J. E. Gershenwald, V. G. Prieto, J. N. Cormier, et al. In Vitro Sensitivity to Ultraviolet B Light and Skin Cancer Risk: A Case-Control Analysis J Natl Cancer Inst, December 21, 2005; 97(24): 1822 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Szekely, E. Remenar, M. Kasler, and S. Gundy Mutagen sensitivity of patients with cancer at different sites of the head and neck Mutagenesis, September 1, 2005; 20(5): 381 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z Ye, H Song, and Y Guo Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis J. Med. Genet., May 1, 2004; 41(5): 360 - 365. [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Zheng, C. A. Loffredo, Z. Yu, R. T. Jones, M. J. Krasna, A. J. Alberg, R. Yung, D. Perlmutter, L. Enewold, C. C. Harris, et al. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls Carcinogenesis, February 1, 2003; 24(2): 269 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Szekely, E. Remenar, M. Kasler, and S. Gundy Does the bleomycin sensitivity assay express cancer phenotype? Mutagenesis, January 1, 2003; 18(1): 59 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Shields Tobacco Smoking, Harm Reduction, and Biomarkers J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chen, D. Tang, K. Xue, L. Xu, G. Ma, Y. Hsu, and S. S. Cho DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population Carcinogenesis, August 1, 2002; 23(8): 1321 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, S. M. Lippman, J. J. Lee, Y. Zhu, Q. V. Wei, M. Thomas, W. K. Hong, and M. R. Spitz Chromosome Instability in Lymphocytes: A Potential Indicator of Predisposition to Oral Premalignant Lesions Cancer Res., May 1, 2002; 62(10): 2813 - 2818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lopez de Mesa, A. Lopez de Cerain Salsamendi, L. S. Ariznabarreta, M. J. C. Abinzano, and A. Patino-Garcia Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients Mutagenesis, March 1, 2002; 17(2): 171 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Shao, M Lai, and Q Huang Mutagen sensitivity and p53 expression in colorectal cancer in China Postgrad. Med. J., November 1, 2001; 77(913): 713 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sudbo, W. Kildal, B. Risberg, H. S. Koppang, H. E. Danielsen, and A. Reith DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia N. Engl. J. Med., April 26, 2001; 344(17): 1270 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-F. Zhang, H. Morgenstern, M. R. Spitz, D. P. Tashkin, G.-P. Yu, T. C. Hsu, and S. P. Schantz Environmental Tobacco Smoking, Mutagen Sensitivity, and Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1043 - 1049. [Abstract] [Full Text]
|
|
|
|
|
|
J. Cloos, C. R. Leemans, M. L. T. van der Sterre, D. J. Kuik, G. B. Snow, and B. J. M. Braakhuis Mutagen Sensitivity as a Biomarker for Second Primary Tumors after Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 713 - 717. [Abstract] [Full Text]
|
|
|
|
|
|
P. G. Shields and C. C. Harris Cancer Risk and Low-Penetrance Susceptibility Genes in Gene-Environment Interactions J. Clin. Oncol., June 11, 2000; 18(11): 2309 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Berwick and P. Vineis Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review J Natl Cancer Inst, June 7, 2000; 92(11): 874 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Schantz, Q. Huang, K. Shah, V.V.V.S. Murty, T.C. Hsu, G. Yu, P. E. Andersen, A. G. Huvos, and R. S.K. Chaganti Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers Carcinogenesis, June 1, 2000; 21(6): 1239 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, H. Yu, C. I. Amos, W. K. Hong, and M. R. Spitz Joint Effect of Insulin-Like Growth Factors and Mutagen Sensitivity in Lung Cancer Risk J Natl Cancer Inst, May 3, 2000; 92(9): 737 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. C. T. van Oijen and P. J. Slootweg Oral Field Cancerization: Carcinogen-induced Independent Events or Micrometastatic Deposits? Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 249 - 256. [Abstract] [Full Text]
|
|
|
|
 |
|
 T.C. Hart, M.L. Marazita, and J.T. Wright The Impact of Molecular Genetics on Oral Health Paradigms Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(1): 26 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-F. Zhang, H. Morgenstern, M. R. Spitz, D. P. Tashkin, G.-P. Yu, J. R. Marshall, T. C. Hsu, and S. P. Schantz Marijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck Cancer Epidemiol. Biomarkers Prev., December 1, 1999; 8(12): 1071 - 1078. [Abstract] [Full Text]
|
|
|
|
|
|
J. Cloos, E. J. C. Nieuwenhuis, D. I. Boomsma, D. J. Kuik, M. L. T. van der Sterre, F. Arwert, G. B. Snow, and B. J. M. Braakhuis Inherited Susceptibility to Bleomycin-Induced Chromatid Breaks in Cultured Peripheral Blood Lymphocytes J Natl Cancer Inst, July 7, 1999; 91(13): 1125 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Sturgis, G. L. Clayman, Y. Guan, Z. Guo, and Q. Wei DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 185 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lai and P. G. Shields The Role of Interindividual Variation in Human Carcinogenesis J. Nutr., February 1, 1999; 129(2): 552 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cloos, C. B.A. Reid, M. L.T. van der Sterre, H. Tobi, C. R. Leemans, G. B. Snow, and B. J.M. Braakhuis A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects Mutagenesis, January 1, 1999; 14(1): 87 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Ko, L. T. Lui, T.-S. Sheen, P.-J. Lou, and M.-M. Hsu Increased Mutagen Sensitivity in Patients With Head and Neck Cancer Is Less Pronounced in Patients With Nasopharyngeal Carcinoma Arch Otolaryngol Head Neck Surg, May 1, 1998; 124(5): 578 - 581. [Abstract] [Full Text] [PDF]
|
|